Skip to Content

Japanese enceph vacc sa14-14-2, inactivated Pregnancy and Breastfeeding Warnings

Japanese enceph vacc sa14-14-2, inactivated is also known as: Ixiaro

Medically reviewed on January 23, 2018

Japanese enceph vacc sa14-14-2, inactivated Pregnancy Warnings

FDA pregnancy category: B

Use only if clearly needed

Animal studies have failed to reveal evidence of teratogenicity.

There are no controlled data in human pregnancy.

FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Japanese enceph vacc sa14-14-2, inactivated Breastfeeding Warnings

Caution is recommended

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

The effects in the nursing infant are unknown.
The U.S. Centers for Disease Control and Prevention (CDC) consider the administration of vaccines compatible with breast-feeding. However, it should be remembered that neonates are too young to be vaccinated and will not be protected against infection.

See references

References for pregnancy information

  1. "Product Information. Ixiaro (Japanese encephalitis virus vaccine SA14-14-2)." Novartis Pharmaceuticals, East Hanover, NJ.

References for breastfeeding information

  1. "Product Information. Ixiaro (Japanese encephalitis virus vaccine SA14-14-2)." Novartis Pharmaceuticals, East Hanover, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide